Background: Although Rapid Maxillary Expansion (RME) has been used for over a century, its effect on upper airways has not yet adequately been assessed in an evidence-based manner. Objective: To investigate the volumetric changes in the upper airway spaces following RME in growing subjects by means of acoustic rhinometry, three-dimensional radiography and digital photogrammetry. Search methods: Literature search of electronic databases and additional manual searches up to February 2016. Selection criteria: Randomized clinical trials, prospective or retrospective controlled clinical trials and cohort clinical studies of at least eight patients, where the RME appliance was left in place for retention, and a maximum follow-up of 8 months post-expansion. Data collection and analysis: After duplicate data extraction and assessment of the risk of bias, the mean differences and 95 per cent confidence intervals (CIs) of upper airway volume changes were calculated with random-effects meta-analyses, followed by subgroup analyses, meta-regressions, and sensitivity analyses. Results: Twenty studies were eligible for qualitative synthesis, of which 17 (3 controlled clinical studies and 14 cohort studies) were used in quantitative analysis. As far as total airway volume is concerned patients treated with RME showed a significant increase post-expansion (5 studies; increase from baseline: 1218.3 mm
Introduction

Rationale
Maxillary expansion as an orthodontic treatment modality has been reported since the 1860s (1) . Rapid Maxillary Expansion (RME) aims to resolve maxillary transverse deficiencies, correct posterior dental crossbites, create arch space for relief of crowding, prevent maxillary canine impaction, and reduce nocturnal enuresis (2) (3) (4) . Separation of the maxillary halves extends directly to the nasal cavity through lateral separation of the nasal walls and lowering of the palatal vault (5) . Reported benefits to the upper airway include improving allergic rhinitis, asthma, and recurrent ear or nasal infections (6) . Many researchers have suggested that RME is a successful means of increasing the nasal permeability and reducing airway resistance, based on both objective and subjective evidence (7, 8) . Reduced airway resistance reduces negative pressure during ventilation, with promising results of RME shown in the treatment of paediatric sleep disordered breathing, including obstructive sleep apnoea (9) . The effects on more distant structures include stretching of the tensor palatine muscles by the expanding maxilla with subsequent improvement in drainage of the Eustachian tubes, aiding in reducing otitis media and conductive hearing loss (10) . Enlarged palatal space may also allow for an improved tongue posture, which could facilitate increased airway space in the oropharynx (11) .
Decreased airflow can be observed in various parts of the upper airways. In cases of considerable obstruction to the nasal airflow, the respiratory pattern can shift towards mouth breathing, although breathing mode cannot be robustly predicted by nasal resistance data alone (8) . On the other side, some researchers suggest that reduced nasal volumes are associated with mouth breathing (12) . The interrelationship between respiratory obstruction, malocclusion, and facial growth continues to be debated after nearly a century of controversy (13) . Interest in this subject has been rekindled in the past decades, based on the possible role of craniofacial morphology, and especially the shape/dimension of the upper airways, on obstructive sleep apnoea (14) .
Many studies have assessed linear transverse dental and skeletal changes produced by maxillary expansion, but these changes do not necessarily reflect airway dimension changes (15, 16) . Previous reports indicate that maxillary expansion is associated with an increase in nasal width, cross-sectional area, and volume (5, 17, 18) . Subjective improvement in nasal breathing has also been considered as a concomitant result (7, 8) . However, evidence on the changes induced by RME on upper airway volumes further from the nasal cavity, particularly the pharynx, is still inconclusive.
Accurate quantification of RME-induced changes at the upper airways has been a challenge. Linear measurements as performed on cephalograms cannot accurately express the upper airways (19) . On the other side, the dimensional accuracy of both conventional computed tomography (CT) and cone-beam CT (CBCT) in quantifying the volume of the upper airway has long been verified (14, 20) with small method error, even though imaging reproducibility of dynamic regions has been suggested to be inconsistent (21) . Although CBCT can offer reduced cost and radiation exposure to the patient compared to traditional CT, the latter shows reduced image noise, improved contrast resolution and accuracy to distinguish between soft tissues and air spaces over the former (22) . Acoustic rhinometry (AR), developed by Hilberg (23) can be used to objectively evaluate the nasal anatomy based on the reflection of sound waves within the nasal cavity. Measurements are then processed to calculate nasal cavity area, volume, and resistance (15) . Use of a decongestant is common to produce readings that are minimally influenced by the highly dynamic nasal mucosal tissues (24) . Although AR has been shown to have good agreement with magnetic resonance imaging and CT in the anterior nasal cavity up to 6 cm from the nostrils (25) , it may over-estimate cross-sectional areas in the posterior portion of the nasal cavity and pharynx, due to partial contribution of the maxillary sinuses (26) .
Objectives
A previous systematic review (27) reported on the subject, however, only studies up to 2010 were included, no meta-analysis was performed, and the quality of overall evidence was not assessed with the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach (28) . The aim of this study was to summarize in systematic manner evidence on upper airway volume changes induced by RME based on clinical studies in growing patients.
Materials and methods
Protocol and registration
The protocol of the present systematic review was based a priori on Cochrane Handbook for Systematic reviews of Interventions 5.1.0. (29) . This systematic review follows the PRISMA statement (30), its extension for abstracts (31) , and was not registered.
Information sources and search
Systematic search of major electronic databases was conducted covering publications in English from inception of each database through 1 February 2016. Electronic searches were performed in MEDLINE via Ovid (1965 to 1 February 2016), PREMEDLINE (all available), Old MEDLINE (1946-65) , Embase (1947 to 1 February 2016), and Cochrane Central Register of Controlled Trials (CENTRAL). Unpublished literature was searched electronically through ClinicalTrials.gov (www.clinicaltrials.gov) and ISRCTN registry (http://www.isrctn.com/) using the terms 'expansion', 'airway', and 'volume' without any limitations to publication date. Additional hand searching of reference lists of relevant articles, grey literature in Google Scholar, and correspondence with experts in the field was conducted for location of any additional studies. The search keywords and strategy were developed in consultation with a senior health sciences librarian and the search was performed independently by two authors (LB and OD). Exact search strategies for MEDLINE via Ovid and Embase are shown in Supplementary Tables 1 and 2 , respectively.
Eligibility criteria
The eligibility criteria of included studies were determined a priori (Supplementary Table 3 ) with the scope of evaluating RME-induced volumetric changes in any region of the upper airway, made with any diagnostic modality. Eligible studies should report both baseline and post-expansion data. In order to minimize the confounding factor of relapse on the immediate volumetric airway changes, it was decided to include only time-points either immediately following the active expansion period or immediately after the retention period (to a maximum of 8 months of retention). Data from follow-up records taken after further non-retained periods, after a subsequent orthodontic treatment phase or at long-term reviews, were not used in order to avoid confounding. Only studies on growing patients (using the cut-off age of 18 years) were included, as skeletal changes produced by RME in this period are more consistent. Due to the scarcity of existing studies, we included randomized and non-randomized controlled clinical trials and non-randomized cohort clinical studies that included at least 8 patients.
Study selection and data collection
Study selection and data collection were conducted by two independent blinded authors (LB and OD), with discrepancies being resolved by discussion with the last author (AKP). Title and abstract screening was performed blinded (32) by these two authors by grading studies as 'yes', 'no', or 'maybe' based on the information provided by the title and abstract. Full text was located for all articles graded with ' yes' or 'maybe', as well as studies where no abstract was available, or the information available was inconclusive in reaching a decision. The inclusion and exclusion criteria were rigorously applied to the full-text articles and where questions remained, efforts were made to contact the authors of the study.
Data collection was performed from the same two blinded authors using a customized data extraction form (Supplementary Table 4 ). The primary outcome measure sought was volumetric changes in any region of the upper airway. The upper airway was defined as including the nose, nasal passages, paranasal sinuses, oral cavity, pharynx (nasopharynx, oropharynx, hypopharynx) (33) and the portion of the larynx above the vocal cords (34) . Information related to the study samples including sample size, age, gender, as well as patient selection criteria were recorded. Details of the type of RME device utilized as well as specifics of the expansion protocol, timing, turning frequency, amount of activation, and retention were retrieved from all included studies. The modality and technique used to quantify the airway volume, as well as the exact time-points that these were recorded were extracted. Measurements were accepted from three specific time-points only, defined as: T1, immediately prior to insertion of RME appliance; T2, immediately at completion of the active expansion phase; and T3, immediately at completion of the retention phase (maximum 8 months).
Risk of bias within individual studies
The Cochrane Collaboration's risk of bias tool (35) was used to assess the internal validity of included randomized controlled trials. The methodological adequacy of included non-randomized trials was assessed with a customized tool that was developed especially for this systematic review based on various appraisal tools (including the Newcastle-Ottawa scale) and empirical evidence of bias in orthodontic clinical research (Supplementary Table 5 ) (36) (37) (38) (39) (40) (41) (42) . The developed checklist comprised 15 individual questions pertaining to four domains: study design, study conduct, statistical analysis, and conclusions, with a maximum score of 25. Studies were graded descriptively as having overall high (score > 20), moderate (20 ≤ score ≤ 13) or low (score < 13) methodological adequacy. However, specific domain questions were also used to determine the strength of the evidence, when drawing conclusions from the final data.
Summary measures
The primary outcome of this systematic review was the overall upper airway volume, as this is the most clinically relevant outcome for the patient. As mentioned above, results from all diagnostic modalities (including AR, CT, etc.) were included, but were analyzed separately. All results were calculated as increment final (post-expansion or post-retention) minus initial (pre-expansion) upper airway volume. As many studies reported on the volume of various parts of the upper airway, we pooled for each study the total airway volume that was reported. As a secondary outcome, we adopted the changes in the volume of each upper airway volume separately and we calculated the RME-induced change likewise. For both primary and secondary outcomes, main emphasis was given on the results of controlled clinical trials, as these have greater internal validity. Results of uncontrolled cohort studies were also reported in order to provide a quantitative overview of the effects of RME on upper airway volume, but were interpreted with caution.
Data synthesis
As the effects of RME were expected to vary among the included studies according to the different treatment protocols, RME appliances, patient characteristics, airway regions, and measurements techniques, a random-effects model according to DerSimonian and Laird (43) was judged appropriate to encompass this variability (44) . For all meta-analyses, the mean differences and the associated 95 per cent confidence intervals (CIs) were calculated. Forest plots were constructed to depict the meta-analysis results and were augmented with contours denoting the magnitude of the observed effects.
Between-trial heterogeneity was quantified with the I 2 statistic, defined as the proportion of total variability in the results explained by heterogeneity, and not chance (45) . The 95 per cent uncertainty intervals (similar to CIs) around the I 2 were calculated using the non-central χ 2 approximation of Q (46). Ninety-five per cent predictive intervals were calculated for meta-analyses of three trials or more, as they incorporate existing heterogeneity and provide a range of possible effects for a future clinical setting, which makes them crucial for the interpretation of random-effects meta-analyses (47) . All analyses were performed using Stata SE 10.0 (StataCorp, College Station, Texas, USA). Statistical significance was set at a two-sided α of 5 per cent, except for test of heterogeneity, where α was set at 10 per cent, due to low power (48) . The overall quality of evidence (confidence in effect estimates) for the primary outcome was rated using the GRADE approach (28) . The GRADE assessment was based on evidence solely from controlled clinical bias, and not from uncontrolled cohort studies, as the latter are more prone to bias. The minimal clinical important, large, and very large effects were conventionally defined (49).
Risk of bias across studies and additional analyses
In meta-analyses of at least five studies, possible sources of heterogeneity were planned a priori to be sought through pre-specified mixedeffects subgroup analyses and random-effects meta-regression with the Knapp and Hartung (50) adjustment according to appliance and patient characteristics. If at least 10 studies were included in a metaanalysis, reporting biases (including the possibility of publication bias) were assessed using contour-enhanced funnel plots (51) and Egger's linear regression test (52) . Sensitivity analyses were planned to be conducted for meta-analyses of at least 10 studies to assess their robustness according to the study design, the improvement of the GRADE classification, and signs of reporting bias.
Results
Study selection
The initial literature search strategy yielded a total of 494 results, while five additional studies were identified from the manual search update (Supplementary Table 6 ). After duplicate removal and initial screening, another 44 studies were excluded after careful application of the eligibility criteria to their full texts, leaving a total 22 papers (15-17, 53-71) (20 unique studies) included in the qualitative synthesis (Figure 1 ). In two instances, two studies pertaining to the same trial were grouped together (55, 57, 69, 71) . A complete list of included and excluded studies with reasons can be found in Supplementary Table 7 . From these, a total of 17 papers (15 unique studies) were included in the quantitative synthesis, as five studies did not adequately report outcome data.
Study characteristics
The characteristics of the 20 studies included in this systematic review are given in Supplementary Tables 8-10 . As far as study design is concerned, one was a randomized controlled clinical trial (53), two were prospective controlled clinical trials (17, 62) , and the remaining 17 were cohort studies [2 retrospective (56, 60) and 15 prospective (15, 16, 54, 55, 57-59, 61, 63-68, 70) in nature]. Data were collected for a total of 483 treated subjects and 55 controls (median of 20 treated and 20 control patients per study). Samples were mixed for size, gender and age of participants (Supplementary Table 8 ). Mean initial age of treated patients ranged from 7.5-14.5 years with an average of 11.9 years. Inclusion criteria varied; however, all involved patients that had transverse maxillary deficiency. In addition, posterior crossbites were compulsory in 10 studies (15, 16, 55, 57, (59) (60) (61) (62) 66) and optional in two studies (54, 58) . The level of skeletal maturation of patients prior to expansion treatment was determined by using the cervical vertebral maturation index in three studies (58, 63, 64) or hand-wrist radiographs in one study (64) . Separation of the maxillary halves by RME was verified, either by radiographic film (15) or recorded as clinical observation of midline diastema formation (64) .
The expansion appliance used in the studies included banded RME in 9 studies (53-56, 58-60, 64, 65), bonded RME in 10 studies (15, 16, 57, 58, (61) (62) (63) (64) (65) (66) , while a study compared banded, bonded and Haas-style RME appliance groups (64) . The cast cup design was used in a study (67) and two studies did not clearly describe type of appliance used (68, 70) . Duration of active expansion varied between studies, representing varied needs of the individual patients. Reported total expansion distances at the screw ranged from 2.7-10.0 mm. While the expansion protocol was well defined in most studies, it was not reported in three of them (57, 58, 65) . Retention techniques varied, with keeping the expander in place passively for some period being the most commonly used practice in 12 studies (15, 17, 53-55, 60, 62-64, 66, 68, 70) , four studies did to outline a retention scheme at all (59, 61, 65, 67) , while the rest of the studies provided inadequate information (16, (56) (57) (58) .
The volume of seven upper airway regions was evaluated in the included studies: nasal cavity, anterior nasal cavity, maxillary sinus, nasopharyngeal, oropharyngeal, hypopharyngeal, and palatal volume. Within the nasal cavity, measurements by both AR and CT were considered. Nasal volume measures by AR were considered with decongestant or without decongestant (also known as basal condition).
All studies recorded baseline volume measurements immediately prior to commencement of RME (T1), five studies (59, 65, 67, 68, 70 ) assessed these volumes again immediately after active expansion (T2) and 15 did so after the retention period (T3). The modalities used to quantify airway volume included AR in 6 studies (15-17, 53, 62, 64) , CBCT in 8 studies (54, 55, 57-59, 67, 68, 70) , CT in 6 studies (16, 56, 60, 61, 63, 65) , surface laser scanning in one study (60) , and photogrammetry in one study (66) .
Risk of bias within studies
The risk of bias assessment for all included randomized and nonrandomized trials is given in Tables 1 and 2 , respectively. The interexaminer consensus was that the risk of bias was high for all included studies. Most common biases observed were selection bias, sampling bias (due to differing inclusion/exclusion criteria), inexistent or problematic randomization, and allocation concealment. Blinding of treatment providers and patients was not feasible, as RME use was obvious, while only one randomized trial (58) attempted blinding during outcome assessment. Performance bias due to differences in care between groups was not deemed to be substantial within individual studies.
Results of individual studies, synthesis of results, and risk of bias across studies
The results of all included studies and the various upper airways volumes that were measured are listed in Supplementary Tables 9 and 10, respectively.
Total airway volume
The results of data synthesis regarding the primary outcome of total airway volume can be seen in Table 3 . As, however, no controlled clinical trials were available, results are based solely on cohort studies of only treated patients and therefore should be interpreted with caution as a quantitative overview of the RME-induced changes on the upper airway. As far as total airway volume is concerned, patients treated with RME showed a significant increase both postexpansion (5 studies; increase from baseline: 1218.3 mm 
Airway volumes of the various regions
As far as changes in the various upper airway regions are concerned, the results of data synthesis are given in Tables 4 and 5 and  Supplementary Table 12 .
The effect of RME on the nasal airway volume could be assessed both from controlled clinical studies and cohort studies of treated patients. As far as controlled studies using AR are concerned, RME was associated with a statistically significant increase in the nasal volume compared to untreated patients both after expansion and after the retention period (Table 4) . Additionally, this increase was consistent in both basal and decongested conditions of the nasal cavity. Assessment of the results with the GRADE approach indicated that the quality of evidence for this increase was 'very low', due to the nature of the included studies and serious methodological limitations (Table 5) .
Additionally, based on cohort studies of treated patients RME was associated with increased nasal cavity volume measured by CT, AR in the basal condition, and AR in the decongested condition, although this was statistically significantly only for the latter. post-retention). However, most of these volumes were not statistically significantly increased from baseline, presumably due to the limited number of contributing studies, their small samples, and the resulting low statistical power. In any case, caution is warranted in the interpretation of these findings, as no control groups were included to factor out the normal growth of the upper airways.
Additional analyses
Due to the limited number of studies in the meta-analyses, subgroup analyses could be performed only for two outcomes: the total airway volume and the total nasal cavity volume, both measured postretention with CT (Supplementary Table 13 ). No significant effect on the RME-induced volume increase could be found for patient age, patient sex, and appliance design. As far as the assessment of reporting biases (including the possibility of publication bias is concerned) only one meta-analysis with at least 10 studies was included, assessing the total airway volume postretention with CT. As can be seen in the contour-enhanced funnel plot ( Figure 3 ) and the results of Egger's test, no considerable indications of reporting biases could be found (Supplementary Table 13 ).
Finally, although various sensitivity analyses were initially planned, these could not be robustly performed, due to the small number and the characteristics of the included studies. The only sensitivity analysis that could be performed was the assessment of difference in the effects between prospective and retrospective studies. Prospective studies tended to report considerably smaller total volume increases after RME compared to retrospective studies (difference = −560.9 mm 3 ; 95 per cent CI = −2139.5 to 1017.8 mm 3 ), although this difference was not statistically significant (P = 0.442).
Discussion
Summary of evidence
This systematic review summarized evidence on the effect of RME on the upper airway volume from clinical studies in humans. However, the results have to be considered with caution, due to the limited number of existing studies and serious methodological issues in their conduct.
In a previous systematic review, Baratieri et al. (27) investigated the long-term effects of RME on airway dimensions and functions. The authors included studies reporting 2D linear measurements from X-rays, nasal volume and minimal cross-sectional areas from CBCTs and AR and functional parameters such as nasal airway resistance and airflow as measured with rhinomanometry. They concluded that moderate evidence exists as to improvement of nasal breathing after RME in growing patients and these results are stable for at least 11 months after treatment. However, in the present systematic review, we expanded the selection criteria in studies that not only evaluated volumetric changes in the nasal cavity but also in all upper airway areas. Moreover, studies reporting results after a retention period of more than 8months were excluded from our study in an attempt to reduce the effect of growth and evaluate the net result of RME.
The main finding of the present review was that RME is associated with an increase in the total volume of the upper airway as well as the volume of the various regions of the upper airway. This increase seemed to be consistent to the various measurement modalities used in the studies and slightly diminished during the retention period. Although the type of expander appliance used varied amongst studies, no considerable differences were found based on appliance design. Additionally, some inconsistency existed across studies with regards to the definition of airway region borders. International consensus on region limits does not currently exist, particularly the landmarks or planes used to demarcate the junction of the nasal cavity and nasopharynx and between regions of the pharynx. This can lead to discrepancies between studies referring to similar airway spaces, although this has a smaller effect on the primary outcome of this review, which was the total airway volume. Also, various study designs were included, which have been shown to be associated with different extents of bias (41, 42) , and this might explain part of the observed variability in the results.
When considering the nasal cavity volume, very low-quality evidence according to the GRADE approach indicates that RME is associated with a modest but consistent increase in volume measured by AR (Table 5 ). This is seen in both basal and decongested conditions, while uncontrolled CT-based evidence from cohort studies seems to back up this notion (Supplementary Table 12 ). Amongst Table 2 . Risk of bias assessment of the included non-randomized studies. AR studies, initial subject age seemed to possibly correlate with the magnitude of the effect size, with younger initial age producing larger effect sizes. This descriptive trend was demonstrated in both decongested and non-decongested groups. Explanation is likely due to the reduced resistance in the bony sutures. Thus, nasal cavity volume increase might be more pronounced in growing young subjects. Additionally, RME appears to increase the volume of the anterior nasal cavity based on CT measurements. The implications of dimensional increases in this zone are important, as it represents the region of greatest nasal airflow-resistance in most people (72) and a number of authors attribute improvements in nasal breathing to nasal valve enlargement (11) .
There is much debate over the validity of CT and CBCT volumetric analysis in the measurement of function airway spaces. Topical contrast agents have been suggested to improve accuracy in defining soft tissue surfaces (73) , an alternative that was not used in any of Figure 2 . Contour-enhanced forest plot for the meta-analysis of the primary outcome (post-pre total airway volume change in mm 3 ) in the patients treated with rapid maxillary expansion. Contours indicate increasing effect magnitude from the middle line-of-no-effect outwards (±2000.0, ±4000.0, ±8000.0 mm 3 used as cut-offs to indicate moderate, large, and very large effects, respectively). Studies to the right indicate that the upper airway volume was increased compared to baseline. CI, confidence interval; NR, not reported; RME, rapid maxillary expansion. the included studies. Only a few studies that use CBCT for airway volume calculation describe using any form of standardization of patient positioning and protocol during image capture. This is particularly relevant in the retrospective studies where airway standardization at capture would be unlikely to have occurred, unless future airway assessments were foreseen at the time. Vertical position in conjunction with a neck-brace and apparatus to orient natural head posture among other standards of breathing, swallowing and occlusion has been incorporated in order to obtain data with minimized variation (54) . It has been shown that airway dimensions change according to head posture (74) and these changes were attributed to gravity acting on the relaxed soft palate, tongue and hyoid bone positions. More precisely, anteroposterior dimensions at the level of the velopharynx and sagittal cross-sectional areas of both velopharynx and oropharynx were decreased in response to body position change from upright to supine when measured in lateral cephalograms (75), indicating another factor that might increase heterogeneity amongst studies. Additionally, pharyngeal airway space (PAS) dimensions are closely related to both sagittal and vertical skeletal pattern. When CBCT reconstructions were used to evaluate linearly and volumetrically the dimensions of PAS in children with different growth patterns, it was found that as the SNB angle was decreasing, linear measurements of PAS at the level of the uvula, uvula tip, mandibular line and back of the tongue also decreased. This trend was also consistent in regards to airway volume, airway area and minimum axial area. Further investigation on the effect of vertical facial type on PAS revealed that the hyperdivergent growth pattern was associated with reduced linear values at the level of the uvula tip. Conclusively, dimensions were significantly reduced in hyperdivergent patients with retrognathic mandibles (76) . In the present systematic review, included studies did not provide information on grouping patients according to initial anteroposterior or vertical relationships. As airway dimensions differ according to the skeletal pattern, an additional confounding factor at the baseline of the included studies increases heterogeneity of the sample and possibly creates individual variations in patients' airway response to RME.
The ethical questions raised regarding the use of a control group relate to withholding RME treatment from a group of patients who are at an appropriate age for it for the purpose of acting as a control and to radiation exposure. Depending on the settings, full CBCT images of the head can produce dosages from 68-368 µSv (77) . Keeping in mind the stochastic nature of the effect of ionizing radiation (78, 79) , it might not be appropriate to subject a control group to multiple radiation exposures in relatively close succession.
Although cross-sectional area and respiratory indices were not considered in this review, the implication of increases in volume in the airway is the potential for improvements in compromised functional respiratory features. Further research in this area is required in order to provide better evidence on the normal growth changes in volumetric parameters during the growth period and possible respiratory effects that may occur from them. Given technological advancements in diagnostics and accuracy, it is hoped that careful attention to experimental design and conduct will allow for future results of sufficient strength to answer these questions more definitively.
As far as the generalizability/applicability of results is concerned, the results of this review might be applicable to the average growing patient with transverse maxillary constriction, as the eligibility criteria used for study selection were broad and most included studies were conducted in pragmatic conditions. As a random-effects model was used for the meta-analysis, the 95 per cent prediction intervals should be used for interpretation; these incorporate existing heterogeneity and provide the range of possible effects of RME on airway volume. However, caution should be exerted during the interpretation of the results, due to the high risk of bias and the fact that subgroup analyses could not be adequately used to describe the ideal candidates for RME.
Strengths and limitations
The strengths of this systematic review include the extensive literature search, the duplicate and blinded review procedures, and the assessment of the quality of evidence with the GRADE approach. All procedures of the qualitative synthesis were conducted under the guidelines of the Cochrane Handbook (29) and the PRISMA statement (30) , while attempts were made to minimize bias during quantitative synthesis (80) , and no signs of reporting bias were identified.
The main shortcoming of this systematic review is the limited number of existing studies, most of which are non-randomized studies with serious methodological limitations. Additionally, most existing studies do not have a control group to reduce the confounding effect of normal growth. As the aim of this review was to determine the immediate effect of RME on airway volume, it was assumed that within the short experimental period of up to 8 months of the included studies the degree of growth effects occurring would be small. The dimensions of children's airways between 6 and 15 years increase at a normal rate of 0.032 cm 2 /year (81), implying that the volume increase found in the present study cannot be attributed to growth alone. However, this cannot be completely ruled out and future well-designed prospective controlled studies are needed to confirm this finding. Additionally, it was not possible to correlate overall the volumetric changes observed with the amount of RME activation because complete data on amount and appliance type was not provided by all studies. Finally, while sources of heterogeneity and robustness of the results were planned to be checked with subgroup and sensitivity analyses, respectively, most of these analyses could not be performed. The clinical heterogeneity at the level of assessed appliances, expansion protocols, chosen outcomes, and measurement methods is evident and precludes any robust clinical suggestions on the effect of RME on upper airway volume.
Conclusions
Evidence from existing controlled and uncontrolled clinical studies indicates that RME in growing patients with transversal maxillary constriction might be associated with a short-term increase in the total upper airway volume and most of the separate airway volumes. However, the results should be interpreted with caution, due to the small number of included trials and serious methodological issues, which might affect the risk of bias. Future well-conducted prospective controlled clinical studies on growing patients are needed in order to recommend the use of RME to increase the upper airway volume in an evidence-based and predictable way.
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